STIM:NASDAQ
Neuronetics Inc
$1.25
arrow_upward
+0.81%(+0.0100) 1D
$1.25
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 20, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$1.20
High
$1.26
Low
$1.12
Mkt. cap
120.60M
Avg. vol.
2.43M
Volume
3.00M
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.33
Beta
1.36
Shares outstanding
77.73M
No. of employees
658
Open
$1.20
High
$1.26
Low
$1.12
Mkt. cap
120.60M
Avg. vol.
2.43M
Volume
3.00M
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.33
Beta
1.36
Shares outstanding
77.73M
No. of employees
658
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
Yahoo Finance
·
1 day ago
Chips suffer worst week since 2001 as the Nasdaq nears a bear market
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorHealth Care
IndustryMedical device
Websiteneurostar.com